The Effect of Physiotherapy on Pain, Functionality and Quality of Life Scores in Patients With Chronic Low Back Pain
Overview
- Phase
- Not Applicable
- Intervention
- Nsaid
- Conditions
- Chronic Low-back Pain
- Sponsor
- Kayseri City Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Visual Analog scale (VAS)
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Demographic data of patients diagnosed with chronic low back pain and planned for medical treatment (n:30) and physical therapy in addition to medical treatment (n:30), as well as before and after treatment; Visual analog scale (VAS), Oswestry Disability Index (ODI) and Short form 36 (SF-36) quality of life scoring, Lumbar range of motion (LHA), straight leg raising test (DBK) and hand-finger ground distance (EPZM) were evaluated. Hot pack, transcutaneous electrical nerve stimulation (TENS) and ultrasound were given as physical therapy agents.
Detailed Description
Patients with VAS, ODI and SF-36 quality of life values before treatment, in addition to demographic data, who have applied to our Physical Medicine and Rehabilitation Policlinic in our hospital with chronic low back pain in the last 3 (three) months, are determined, and at least 30 above the age of 18 who received physiotherapy and who did not receive physiotherapy. patient consents obtained and VAS, ODI and SF-36 quality of life values questioned. Pre- and post-treatment values compared, and intragroup changes compared in both groups and evaluated whether physiotherapy contributes to pain, functionality and quality of life in treatment.
Investigators
Havva Talay Çalış
Prof.Dr.
Kayseri City Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients who have been prescribed medical treatment or physiotherapy for mechanical back pain
- •Those with demographic information as well as VAS, ODI information in their files
- •Patients between the ages of 20-79 who applied to our hospital with the complaint of chronic low back pain
Exclusion Criteria
- •Non-mechanical back pain
- •Patients with physiotherapy contraindications
- •Those with inflammatory diseases
- •Severe heart failure
- •Stroke, spinal cord injury, plegia due to traumatic brain injury
- •A history of malignancy
- •Active infection during treatment
- •Having metal implants in the waist area
- •Established osteoporosis
- •Those with pacemakers
Arms & Interventions
Group 1
NSAID
Intervention: Nsaid
Group 2
nsaid and physiotherapy
Intervention: Nsaid
Group 2
nsaid and physiotherapy
Intervention: Phsiotheraphy
Outcomes
Primary Outcomes
Visual Analog scale (VAS)
Time Frame: at baseline and immediately after treatment
It is a scale used to evaluate pain intensity. Patients are asked to mark the severity of their pain on a 10 cm line. Patients are asked to mark the place expressing their pain on a line on the scale, where the starting point is no pain and the end point is the most severe pain experienced in life. When calculating, the distance between the marked point and the starting point is measured in cm. An increase in the score means that the severity of pain increases.
Oswestry Disability Index (ODI)
Time Frame: at baseline and immediately after treatment
It is a valid and reliable scoring in Turkish to evaluate the degree of loss of function in low back pain. It consists of 10 items that question pain severity, self-care, lifting and carrying loads, walking, sitting, standing, sleeping, degree of pain change, travel and social life. Each item is scored between "0" and "5". The maximum score is "100" and the minimum score is "0". The results are evaluated as 0-20 points if it minimally affects daily life, 20-40 points if it is moderate, 40-60 points if it is serious, 60-80 points if it completely restricts it, and 80-100 points if it is bedridden. The disability percentage can be calculated by converting the total score obtained into a percentage system. As the total score increases, the level of disability also increases.
Secondary Outcomes
- Straight leg raising(at baseline and immediately after treatment)
- Finger-to-ground distance(at baseline and immediately after treatment)
- SF 36(at baseline and immediately after treatment)
- range of motion (ROM)(at baseline and immediately after treatment)